Insiders Q32 Bio Inc.

Equities

QTTB

US7469641051

Market Closed - Nasdaq Other stock markets 21:00:00 14/05/2024 BST			5-day change	1st Jan Change
28.42 ^USD	+2.41%		+4.52%	+159.69%

05-09	Q32 Bio Inc. Provides Corporate Update	CI
04-11	Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neurogene Names Julie Jordan as Chief Medical Officer	01-16	MT
Homology Medicines, Inc. Approves Reduction in Workforce	27/07/23	CI
Homology Medicines, Inc. Announces Promotion of Julie Jordan to Chief Medical Officer	09/03/23	CI
Homology Medicines Promotes Chief Scientific Officer Albert Seymour to CEO	06/09/22	MT
Homology Medicines, Inc. Appoints Albert Seymour as Chief Executive Officer	06/09/22	CI
Homology Medicines, Inc. Announces Promotion of Albert Seymour to Member of the Board of Directors	06/09/22	CI
Homology Medicines, Inc. Announces Promotion of Albert Seymour to President	21/04/22	CI
Homology Medicines, Inc. Announces Resignation of Tim Kelly as Chief Operating Officer	03/02/22	CI
Homology Medicines, Inc. Appoints Beverly Davidson as Chair of Scientific Advisory Board	05/08/21	CI
Homology Medicines, Inc. Appoints Beverly Davidson, Ph.D., as Chair of Scientific Advisory Board	05/08/21	CI
Homology Medicines, Inc. Announces Promotion of Tim Kelly to Chief Operating Officer	12/04/21	CI
Insider Trends: Insider Sales Add to 90-Day Trend at Homology Medicines	08/01/21	MT
Insider Trends: Insider Adds to Selling Trend at Homology Medicines	07/01/21	MT
Insider Trends: Homology Medicines Insider Continues 90-Day Selling Trend	29/12/20	MT
Insider Trends: Insider Sales Continue 90-Day Trend at Homology Medicines	29/12/20	MT
Insider Trends: Selling By Insiders Lingers at Homology Medicines	17/12/20	MT
Insider Trends: Insider Adds to Selling Trend at Homology Medicines	17/12/20	MT
Homology Medicines Appoints Jeff Poulton to the Board of Directors	21/07/20	CI
Homology Medicines, Inc. Appoints Gabriel M. Cohn as Chief Medical Officer	03/12/19	CI
Homology Medicines, Inc. Announces Board Changes	15/07/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Q32 Bio Inc.

Equities

QTTB

US7469641051

Insiders

Filters